BioAtla Stock (BCAB)
Track BioAtla stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
BCAB
BioAtla
healthcare
$1.50
▼ -44.13 (-96.61%) past year
Market Cap
$2.58M
P/E Ratio
—
1Y Return
-96.61%
EPS (TTM)
-$25.56
Read the latest TheStreet Pro articles mentioning BioAtla, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning BCAB yet.
Daily Diary Mentions
0 mentionsNo diary mentions for BCAB yet.